image
ProQR Therapeutics N.V. PRQR
Healthcare - Biotechnology - NASDAQ - NL
Watchlist
$ 3.82
-3.29 %
$ 394 M
Market Cap
-12.32
P/E
INCOME STATEMENT
6.51 M REVENUE
61.36%
Growth Rates
1Year 61.36%
3Years 0.00%
5Years 5.68%
7Years 16.17%
10Years 0.00%
-31.9 M OPERATING INCOME
50.77%
Growth Rates
1Year 50.77%
3Years 9.06%
5Years 2.57%
7Years 3.05%
10Years -25.68%
-27.5 M NET INCOME
57.56%
Growth Rates
1Year 57.56%
3Years 16.09%
5Years 5.78%
7Years 4.89%
10Years -23.81%
EFFICIENCY
Earnings Waterfall ProQR Therapeutics N.V.
image
Revenue 6.51 M
Cost Of Revenue 134 K
Gross Profit 6.38 M
Operating Expenses 38.4 M
Operating Income -31.9 M
Other Expenses -4.32 M
Net Income -27.5 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
REVENUE
Revenue 6.5 4.0 1.4 0 1.9 4.9 (1.5) 2.3 9.4 0.3 0
GROSS PROFIT
Cost Of Revenue 0.1 2.5 0 2.2 116.8 1.0 1.0 1.3 0.5 0 0
Gross Profit 6.4 1.6 1.4 (2.2) (114.9) 4.0 (2.5) 1.0 8.9 0.3 0
OPERATING INCOME
Operating Expenses 38.4 68.8 58.5 51.8 59.4 42.1 42.0 41.4 30.2 16.8 3.2
Selling, General and Administrative Expenses 16.2 18.7 17.4 13.7 12.9 12.5 10.8 9.5 6.8 6.5 0.8
Research and Development Expenses 25.1 50.9 42.2 38.1 46.5 29.5 31.2 31.9 23.4 10.3 2.6
Operating Income (31.9) (64.7) (57.2) (42.4) (57.4) (36.3) (40.5) (39.6) (27.0) (16.5) (3.2)
PRE-TAX INCOME
Interest Income Expense 1.2 5.1 3.4 2.0 1.1 0.8 0.6 0.5 0.4 0.3 38 K
Total Other Income 4.0 1.1 (3.5) (4.1) 117.7 (0.8) 0.9 0.5 6.2 4.3 14 K
Pre-Tax Income (27.8) (64.8) (61.6) (46.5) (56.6) (37.1) (43.7) (39.1) (20.8) (12.1) (3.3)
NET INCOME
Tax Provision 78 K 96 K 0.1 0.1 0.1 1 K 2 K (0.5) (6.2) (4.3) 24 K
Net Income (28.1) (64.9) (61.7) (46.6) (56.7) (36.9) (43.6) (39.1) (20.8) (12.1) (3.3)
EPS 0.35 0.91 0.96 0.93 1.38 1.08 1.72 1.67 0.89 1.09 0.15